UK NEQAS for Immunocytochemistry & In-Situ Hybridisation (UK NEQAS ICC & ISH)

London, United KingdomAccepts international participants

Accreditation self-declared (UKAS)

UK NEQAS scheme hosted by External Quality Assessment Services for Cancer Diagnostics CIC that assesses immunohistochemistry and in-situ hybridisation in cellular pathology laboratories, with modules for general, breast, lymphoid, neuro, cyto and gastrointestinal pathology and predictive markers such as HER2, ALK, PD-L1 and mismatch repair proteins.

Testing fields

  • Molecular diagnostics & genetics
  • Histopathology & cytology

Schemes (12)

Accreditation

Status
Accreditation self-declared
Accreditation body
UKAS
Certificate number
7833

Self-declared: stated by the provider and not yet verified by EqasOnline.

About this listing

Compiled from UK NEQAS for Immunocytochemistry & In-Situ Hybridisation (UK NEQAS ICC & ISH)'s own published information or sent in by the provider, and reviewed by EqasOnline. Check scheme details, fees and dates with the provider before you enrol. 12 schemes listed here.

Last updated 29 Oct 2026.

Is this your organisation, or is something out of date? Update this listing.